|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
FLAG-tag, or FLAG octapeptide, is a polypeptide protein tag that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild-type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A FLAG-tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a FLAG-tag to this protein allows one to follow the protein with an antibody against the FLAG sequence. Examples are cellular localization studies by immunofluorescence or detection by SDS PAGE protein electrophoresis.
The peptide sequence of the FLAG-tag from the N-terminus to the C-terminus is: DYKDDDDK (1012 Da). It can be used in conjunction with other affinity tags, for example a polyhistidine tag (His-tag), HA-tag or Myc-tag. It can be fused to the C-terminus or the N-terminus of a protein. Some commercially available antibodies (e.g., M1/4E11) recognize the epitope only when it is present at the N-terminus. However, other available antibodies (e.g., M2) are position-insensitive.
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-GFPSpark 標籤||DG70014-ACG|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-OFPSpark 標籤||DG70014-ACR|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-Flag 標籤||DG70014-CF|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-His 標籤||DG70014-CH|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-Myc 標籤||DG70014-CM|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), C-HA 標籤||DG70014-CY|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF(克隆載體)||DG70014-G|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), N-Flag 標籤||DG70014-NF|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), N-His 標籤||DG70014-NH|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), N-Myc 標籤||DG70014-NM|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體), N-HA 標籤||DG70014-NY|
|狗 IL2/IL-2/Interleukin-2 基因全長cDNA ORF克隆 (表達載體)||DG70014-UT|
Interleukin-2, also known as T-cell growth factor, TCGF, Aldesleukin and IL2, is a secreted protein which belongs to the IL-2 family. Interleukin-2 / IL-2 was the first interleukin molecule to be discovered. Interleukin-2 / IL-2 molecule was first purified to homogeneity by immunoaffinity chromatography by Kendall Smith and his team at Dartmouth Medical School. Interleukin-2 / IL-2 was also the first cytokine shown to mediate its effects via a specific IL-2 receptor, and it was also the first interleukin to be cloned and expressed from a complementary DNA (cDNA) library. Interleukin-2 / IL-2 was designated number 2 because Smith's data at the time indicated that IL-1, produced by macrophages, facilitates IL-2 production by T lymphocytes (T cells).
Interleukin-2 / IL-2 is produced by T-cells in response to antigenic or mitogenic stimulation, this protein is required for T-cell proliferation and other activities crucial to regulation of the immune response. Interleukin-2 / IL-2 is normally produced by the body during an immune response. When environmental substances (molecules or microbes) gain access to the body, these substances (termed antigens) are recognized as foreign by antigen receptors that are expressed on the surface of lymphocytes. Antigen binding to the T cell receptor (TCR) stimulates the secretion of Interleukin-2 / IL-2, and the expression of IL-2 receptors IL-2R. The IL-2 / IL-2R interaction then stimulates the growth, differentiation and survival of antigen-selected cytotoxic T cells via the activation of the expression of specific genes. Interleukin-2 / IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells. The World Reference Standard for Interleukin-2 / IL-2 is produced by the National Institute of Biological Standards and Control in the UK. A recombinant form of Interleukin-2 / IL-2 for clinical use is manufactured by Chiron Corporation with the brand name Proleukin. It has been approved by the Food and Drug Administration (FDA) for the treatment of cancers (malignant melanoma, renal cell cancer), and is in clinical trials for the treatment of chronic viral infections, and as a booster (adjuvant) for vaccines. The use of Interleukin-2 / IL-2 in HIV therapy has been found to be ineffective.